Kringle Pharma, Inc.
4884
Rank in Stocks
#24455
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Share Price
$3.61
Last synced: 2026-11-19
Market Cap
$31.45M
Change (1 day)
9.62%
Change (1 year)
37.53%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Kringle Pharma, Inc. (4884)
Category
Healthcare
Operating Margin for Kringle Pharma, Inc. (4884)
Operating Margin as of November 2026 TTM: -183.96%
According to Kringle Pharma, Inc.'s latest financial reports, its current operating margin (TTM) is -183.96%. At the end of 2025 the company had an operating margin of -1,259.37%.
Operating Margin history for Kringle Pharma, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -183.96% | -85.39% |
| 2025 | -1,259.37% | 23.24% |
| 2024 | -1,021.87% | -20.38% |
| 2023 | -1,283.41% | 1,080.04% |
| 2022 | -108.76% | -11.94% |
| 2021 | -123.51% | 236.54% |
| 2020 | -36.70% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | -98.94% |
US
|
|
| 33.87% | -100.18% |
US
|
|
| -116.04% | -99.37% |
US
|
|
| 25.57% | -100.14% |
AU
|
|
| 31.23% | -100.17% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Kringle Pharma, Inc.'s operating margin
What is Kringle Pharma, Inc.'s operating margin?
Kringle Pharma, Inc.'s operating margin is -183.96%, as of Nov 2026.
What was Kringle Pharma, Inc.'s operating margin in 2025?
In 2025, Kringle Pharma, Inc.'s operating margin was -1,259.37%, compared with -1,021.87% in 2024.
How has Kringle Pharma, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Kringle Pharma, Inc.'s operating margin was highest in 2020 (-36.70%) and lowest in 2023 (-1,283.41%).
How does Kringle Pharma, Inc.'s operating margin compare with similar companies?
Kringle Pharma, Inc.'s operating margin (-183.96%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.